Jardiance Met 12.5/500mg Tablet 10's

Jardiance Met 12.5 mg /500 mg tablet is a combination of two anti-diabetic medications, used to treat type 2 diabetes mellitus. Each film coated Jardiance Met 12.5 mg /500 mg tablet contains Empagliflozin 12.5 mg, Metformin Hydrochloride 500 mg and Excipients q.s. Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor, inhibits the SGLT2 co-transporter, which leads to lower reabsorption of filtered glucose into the body and decreases the renal threshold for glucose (RTG), leading to increased glucose excretion in the urine. Metformin is a biguanide antihyperglycaemic agent which improves glucose tolerance by lowering both basal and postprandial plasma glucose. It decreases hepatic glucose production, delays intestinal glucose absorption, and improves insulin sensitivity by enhancing peripheral glucose uptake and utilization.